Sandeep S M, Banait Vaibhav S, Thakur Sanjeev K, Bapat Mukta R, Rathi Pravin M, Abraham Philip
Department of Gastroenterology, Seth G S Medical College and K E M Hospital, Mumbai - 400 012, India.
Indian J Gastroenterol. 2006 May-Jun;25(3):125-7.
Percutaneous drainage or surgery is required when amebic liver abscess (ALA) fails to respond to medical management. In some of these patients, non-response may be due to communication of ALA with the biliary tree. This report describes our experience with the use of endoscopic biliary draining in such patients.
Medical records of patients with ALA undergoing either needle aspiration or percutaneous pigtail drainage were retrieved; the indications for drainage were: abscess volume exceeding 250 mL, a thin rim of tissue (< 1 cm thick) around the abscess, systemic toxic features and failure to improve on medical treatment. Patients with abscess drain output >25 mL/day persisting for 2 weeks or presence of bile in the drain fluid underwent endoscopic biliary drainage.
A total of 115 patients with ALA underwent percutaneous treatment. None of the 25 patients with needle aspiration needed any further treatment. Of the 90 who underwent catheter drainage, the catheter could be removed within one week in 77 patients; the remaining 13 patients (median age 42 years, range 24-65; all men) had an abscess-biliary communication. In them, the median catheter output was 88 mL/day (range 45-347) and 54 mL/day (28-177) at 2 days and 2 weeks after catheter placement. The drain fluid contained bile in all 13 patients and in addition contained pus in 10 patients. Eleven patients had a solitary abscess and two had multiple abscesses. Cholangiogram showed biliary communication in all 13 patients. All patients were treated with placement of 10F biliary endoprosthesis or 10F nasobiliary drain. Pigtail catheter was removed within 1 week in 11 of 13 patients.
In patients with amebic liver abscess communicating with the biliary tree, biliary stenting may hasten clinical recovery and allow early removal of liver abscess catheter drain.
当阿米巴肝脓肿(ALA)对药物治疗无反应时,需要进行经皮引流或手术治疗。在这些患者中,部分患者无反应可能是由于ALA与胆管树相通。本报告描述了我们在此类患者中使用内镜胆管引流的经验。
检索接受针吸或经皮猪尾引流的ALA患者的病历;引流指征为:脓肿体积超过250 mL、脓肿周围组织薄边缘(<1 cm厚)、全身中毒症状以及药物治疗无改善。引流液每日超过25 mL持续2周或引流液中出现胆汁的患者接受内镜胆管引流。
共有115例ALA患者接受了经皮治疗。25例接受针吸的患者均无需进一步治疗。90例接受导管引流的患者中,77例患者的导管可在1周内拔除;其余13例患者(中位年龄42岁,范围24 - 65岁;均为男性)存在脓肿与胆管相通。其中,置管后2天和2周时,导管引流量中位数分别为88 mL/天(范围45 - 347)和54 mL/天(28 - 177)。13例患者的引流液中均含有胆汁,其中10例还含有脓液。11例患者为单个脓肿,2例为多个脓肿。胆管造影显示所有13例患者均存在胆管相通。所有患者均接受了10F胆管内支架置入或10F鼻胆管引流治疗。13例患者中有11例在1周内拔除了猪尾导管。
对于阿米巴肝脓肿与胆管树相通的患者,胆管支架置入可能会加速临床康复并允许早期拔除肝脓肿导管引流。